Carisma Therapeutics Inc. Restricted Cash, Current
Carisma Therapeutics Inc. had Restricted Cash, Current of $21.00 million as of 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Restricted Cash and Cash Equivalent, Current
us-gaap:RestrictedCashCurrent · last filed 2023-02-28
- 2022-12-31: Restricted Cash, Current $21.00M.
- 2021-12-31: Restricted Cash, Current $0.00.
- 2021-09-30: Restricted Cash, Current $0.00.
- 2021-06-30: Restricted Cash, Current $0.00.
| Period end | Restricted Cash, Current |
|---|---|
| 2022-12-31 | $21.00M 10-K · filed 2023-02-28 |
| 2021-12-31 | $0.00 10-K · filed 2023-02-28 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-08 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-09 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-10 |
| 2020-12-31 | $3.00M 10-K · filed 2023-02-28 |
| 2019-12-31 | $0.00 10-K · filed 2022-02-28 |
| 2018-12-31 | $0.00 10-K · filed 2021-03-15 |